Tao Feng
P.R. China
Shanghai, 200032, China
Shanghai, 200032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Mechanistic insights into pharmacokinetic interactions between simvastatin and vismodegib: Implications for optimization of combination therapy in medulloblastoma.
Journal: Biochemical and biophysical research communications
Published: August 20, 2025
Hsa_circ_0038737 promotes PARPi resistance in castration-resistant prostate cancer via IGF2BP3-mediated DNPH1 mRNA stabilization.
Journal: Molecular cancer
Published: May 27, 2025
DPP9 inhibition boosts antitumor immunity by disrupting BRISC-mediated PD-L1 expression in clear cell renal cell carcinoma.
Journal: Cell death and differentiation
Published: April 12, 2025
Lon protease 1-mediated metabolic reprogramming promotes the progression of prostate cancer.
Journal: Cell death & disease
Published: June 18, 2024
MYO6 contributes to tumor progression and enzalutamide resistance in castration-resistant prostate cancer by activating the focal adhesion signaling pathway.
Journal: Cell communication and signaling : CCS
Published: June 18, 2024
Machine Learning-based Framework Develops a Tumor Thrombus Coagulation Signature in Multicenter Cohorts for Renal Cancer.
Journal: International journal of biological sciences
Published: January 22, 2024
Deciphering the prognostic features of bladder cancer through gemcitabine resistance and immune-related gene analysis and identifying potential small molecular drug PIK-75.
Journal: Cancer cell international
Published: November 18, 2023
Calycosin inhibits the proliferation and metastasis of renal cell carcinoma through the MAZ/HAS2 signaling pathway.
Journal: Phytotherapy research : PTR
Published: November 18, 2023
Correction to: The function and mechanisms of action of circular RNAs in Urologic Cancer.
Journal: Molecular cancer
Published: April 24, 2023
Last Updated: 09/26/2026